Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidekatsu Yanai

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Journal of Clinical Medicine Research|April 3, 2019
Associations of Pericardial Fat Area Determined by Routine Chest Computed Tomography With Coronary Risk Factors and Coronary Artery DiseaseReo Yoshikawa, Hidekatsu Yanai, Sumie Moriyama, et al.
Integrated Blood Pressure Control|September 28, 2011
Antihypertensive effects of astaxanthinHidekatsu Yanai, Kumie Ito, Hiroshi Yoshida, et al.
International Journal of Molecular Sciences|April 30, 2021
Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 InhibitorsHidekatsu Yanai, Mariko Hakoshima, Hiroki Adachi, et al.
International Journal of Molecular Sciences|September 10, 2021
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney DiseaseHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cardiology Research|November 21, 2022
A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 DiabetesHidekatsu Yanai, Mariko Hakoshima, Hiroki Adachi, et al.
Biology|May 27, 2023
Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic ComplicationsHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Annals of Clinical Biochemistry|May 16, 2023
Measurement of cholesterol levels of lipoprotein subclasses in human serum using anion-exchange high-performance liquid chromatography with a linear concentration gradient of sodium perchlorateRiku Ito, Daisuke Manita, Hidekatsu Yanai, et al.
Journal of Clinical Medicine Research|July 11, 2025
The Long-Term Effects of the Selective Inhibitor of Urate Transporter 1, Dotinurad, on Metabolic Parameters and Renal Function in Japanese Patients With Asymptomatic HyperuricemiaHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
International Journal of Molecular Sciences|April 12, 2022
Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its TreatmentHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Biomedicines|February 25, 2023
Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal StudyHidekatsu Yanai, Hisayuki Katsuyama, Mariko Hakoshima, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Journal of Clinical Medicine Research|April 3, 2019
Associations of Pericardial Fat Area Determined by Routine Chest Computed Tomography With Coronary Risk Factors and Coronary Artery DiseaseReo Yoshikawa, Hidekatsu Yanai, Sumie Moriyama, et al.
Integrated Blood Pressure Control|September 28, 2011
Antihypertensive effects of astaxanthinHidekatsu Yanai, Kumie Ito, Hiroshi Yoshida, et al.
International Journal of Molecular Sciences|April 30, 2021
Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 InhibitorsHidekatsu Yanai, Mariko Hakoshima, Hiroki Adachi, et al.
International Journal of Molecular Sciences|September 10, 2021
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney DiseaseHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Cardiology Research|November 21, 2022
A Significant Effect of Oral Semaglutide on Cardiovascular Risk Factors in Patients With Type 2 DiabetesHidekatsu Yanai, Mariko Hakoshima, Hiroki Adachi, et al.
Biology|May 27, 2023
Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic ComplicationsHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Annals of Clinical Biochemistry|May 16, 2023
Measurement of cholesterol levels of lipoprotein subclasses in human serum using anion-exchange high-performance liquid chromatography with a linear concentration gradient of sodium perchlorateRiku Ito, Daisuke Manita, Hidekatsu Yanai, et al.
Journal of Clinical Medicine Research|July 11, 2025
The Long-Term Effects of the Selective Inhibitor of Urate Transporter 1, Dotinurad, on Metabolic Parameters and Renal Function in Japanese Patients With Asymptomatic HyperuricemiaHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
International Journal of Molecular Sciences|April 12, 2022
Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its TreatmentHidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
Biomedicines|February 25, 2023
Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal StudyHidekatsu Yanai, Hisayuki Katsuyama, Mariko Hakoshima, et al.
Pageof 13